Figure 5
Comparison of R69W mutant versus wild-type MCP in inhibiting the alternative complement pathway. FACS analysis of C3d deposition using 1, 4, or 8.3 mg/mL of sensitizing Ab with 10% or 30% C7d serum for 60 minutes in Mg2+-EGTA. Representative experiment of 3. See Table 3 for MFIs.
